US2025129520A1PendingUtilityA1
Wet-spun lamin-based fibers
Assignee: SAMI SHAMOON COLLEGE OF ENGPriority: Sep 19, 2021Filed: Sep 19, 2022Published: Apr 24, 2025
Est. expirySep 19, 2041(~15.1 yrs left)· nominal 20-yr term from priority
Inventors:Cfir Ben Harush
D10B 2401/063D06M 2200/12D06M 2101/34D06M 23/10D06M 13/02D06M 15/53D06M 2101/16D01F 6/68D06M 13/2243D06M 2101/14D06M 15/643D06M 2101/12D06M 13/224D01D 5/06D01F 4/00
34
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Fibers comprising a lamin-based protein, wherein the fiber is characterized by a diameter between 10 μm and 180 μm are disclosed. Further, articles comprising the fibers and methods for producing same are disclosed.
Claims
exact text as granted — not AI-modified1 .- 45 . (canceled)
46 . A fiber comprising a lamin-based protein, wherein said fiber is characterized by an average diameter between 1 μm and 1000 μm, and by an average length of at least 1 mm.
47 . The fiber of claim 46 , wherein said fiber is in contact with a hydrophobic coating layer comprising a water immiscible compound.
48 . The fiber of claim 47 , wherein said water immiscible compound is selected from a vegetable oil, a mineral oil, a fatty acid, a fatty acid ester, a lipid, isobutyl-stearate, tallow fatty acid 2-ethylhexyl ester, polyol carboxylic acid ester, a glyceride, coconut oil fatty acid ester of glycerol, alkoxylated glycerol, a silicone oil, dimethyl polysiloxane, and a wax, including any copolymer, any salt, or any combination thereof, wherein said hydrophobic coating layer is characterized by an average thickness between 1 nm and about 20 μm.
49 . The fiber of claim 46 , wherein the lamin-based protein undergoes α-helix to β-sheet transition upon stretching of said fiber to a strain of about 6%; and wherein said fiber is characterized by an average diameter between about 10 μm and about 1000 μm.
50 . The fiber of claim 49 , wherein the average diameter of said fiber is between about 10 μm and 180 μm; and wherein said α-helix to β-sheet transition comprises at least 20% α-helix to β-sheet transition as determined by RAMAN spectroscopy.
51 . The fiber of claim 46 , wherein upon stretching of said fiber to a strain of between about 6% and about 50%, the lamin-based protein is characterized by a β-sheet content of between about 30 and about 50%.
52 . The fiber of claim 46 , wherein said lamin-based protein comprises an A-type lamin, a B-type lamin or both.
53 . The fiber of claim 52 , wherein said B-type lamin comprises an amino acid sequence as set forth in SEQ ID NO: 1, wherein X 1 comprises Gln or Lys, including any functional analog having at least 70% sequence homology thereto; optionally wherein said fiber further comprises any of: (i) an N-terminal region comprising the amino acid sequence as set forth in SEQ ID NO: 2, including any functional analog having at least 70% sequence homology thereto; and (ii) a C-terminal region comprising the amino acid sequence as set forth in SEQ ID NO: 3, including any functional analog having at least 70% sequence homology thereto.
54 . The fiber of claim 52 , wherein said A-type lamin comprises an amino acid sequence as set forth in SEQ ID NO: 4, or as set forth in SEQ ID NO: 7, wherein X 2 is Glu or Lys, including any functional analog having at least 70% sequence homology thereto; optionally further comprising any of: (i) an N-terminal region comprising the amino acid sequence as set forth in SEQ ID NO: 5; and (ii) a C-terminal region comprising the amino acid sequence as set forth in SEQ ID NO: 6, or as set forth in SEQ ID NO: 8.
55 . The fiber of claim 46 , wherein said fiber is characterized by a diameter between about 20 μm and about 80 μm; and wherein said fiber is characterized by at least one mechanical property selected from:
yield strength between about 1 MPa and about 1000 MPa;
tensile strength between about 1 MPa and about 1000 MPa;
fracture strain between about 80% and about 1000%;
toughness between about 30 MJ/m 3 and about 1000 MJ/m 3 and
a Young's Modulus between about 0.001 GPa and about 30 GPa.
56 . The fiber of claim 53 , wherein X 1 is Gln, and the fiber is characterized by any of: (i) a residual amount of an alcohol; (ii) toughness of greater than about 190 MJ/m 3 and (ii) said protein is characterized by a α-helix to β-sheet transition upon stretching thereof to a strain of about 6%; optionally wherein said fiber is characterized by average diameter between about 30 and about 60 μm.
57 . The fiber of claim 56 , further comprising any of:
i. an N-terminal region comprising the amino acid sequence SEQ ID NO: 2 or any functional analog having at least 70% sequence homology thereto; ii. a C-terminal region comprising the amino acid sequence SEQ ID NO: 3 or any functional analog having at least 70% sequence homology thereto.
58 . The fiber of claim 46 , wherein said fiber is a stretched fiber; and wherein said lamin-based protein within said stretched fiber and is characterized by a α-helix: β-sheet ratio between 5:1 and 1:1.
59 . The fiber of claim 46 , wherein said lamin-based protein is arranged within said fiber in a form of paracrystals; wherein each of said paracrystals is characterized by a dimension selected from: (i) a width between 1 nm and 500 nm; (ii) a length between 0.5 mm and 1 cm, or both (i) and (ii); optionally wherein said lamin-based protein is an isolated protein.
60 . An article comprising a plurality of fibers of claim 46 .
61 . The article of claim 60 , being in a form of a yarn, a mesh, a woven substrate, a non-woven substrate, a composite material, or any combination thereof.
62 . A method for obtaining the fiber of claim 46 , comprising the steps of:
providing a lamin-based protein solution; and injecting said lamin-based protein solution into a coagulation solution comprising an alcohol, thereby forming said fiber.
63 . The method of claim 62 , wherein said coagulation solution is characterized by a viscosity between 0.45 cP and 3 cP, or more than 0.7 cP; and wherein said injecting is at a flow rate of at least 0.1 ml/h.
64 . The method of claim 62 , wherein said alcohol is selected from methanol (MeOH), ethanol (EtOH), propanol (PrOH), isopropyl alcohol (IPA), butanol, pentanol, or any combination thereof; and wherein said coagulation solution comprises between 50% (v/v) and 100% (v/v) of said alcohol.
65 . The method of claim 62 , wherein concentration of said lamin-based protein in the lamin-based protein solution is between 10 mg/mL and 400 mg/mL.Join the waitlist — get patent alerts
Track US2025129520A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.